- About Us
- Career Center
- Nano-Social Network
- Nano Consulting
- My Account
Patent Attorney Prewitt to Join Portland Office of Schwabe, Williamson & Wyatt
Portland, OR | May 11, 2005
Patent attorney Steven Prewitt joins Schwabe, Williamson & Wyatt as an associate in the firm’s Portland office, further growing the firm’s expertise serving life science and technology clients.
Prewitt adds to Schwabe’s nanotechnology and microtechnology law practice group, the first of its kind in the Pacific Northwest. Another recent addition to this 20-lawyer practice group, Andrew Barofsky, joined in September 2004.
“With the current addition of Steve, and recent addition of Andrew, Schwabe continues to grow its patent and IP services for Northwest life science and technology companies,” said Al AuYeung, shareholder and co-chair of Schwabe’s Intellectual Property Practice Group and its Nanotechnology and Microtechnology Practice Group.
About Schwabe, Williamson & Wyatt:
Schwabe, Williamson & Wyatt is a regional, multi-service law firm with 150 attorneys in Portland, Bend, and Salem, Oregon, and Seattle, Stevenson and Vancouver, Washington, and in Washington D.C. Schwabe attorneys provide a broad range of transaction and litigation services to many of the Pacific Northwest's leading companies, from Fortune 500 industry leaders, to emerging and small, family-owned businesses. Schwabe ranked 15th in Oregon Business magazine's 100 Best Companies To Work For in 2005.
Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
|Related News Press|
Graphene leans on glass to advance electronics: Scientists' use of common glass to optimize graphene's electronic properties could improve technologies from flat screens to solar cells February 12th, 2016
Breaking cell barriers with retractable protein nanoneedles: Adapting a bacterial structure, Wyss Institute researchers develop protein actuators that can mechanically puncture cells February 12th, 2016
Properties of Polymeric Nanofibers Optimized to Treat Damaged Body Tissues February 12th, 2016
Silicon-based metamaterials could bring photonic circuits February 1st, 2016
Therapeutic Solutions International Licenses Dexosome Clinical Stage Cancer Immunotherapy Product From Gustave Roussy European Cancer Centre: FDA Cleared Immuno-Oncology Technology to Resume Clinical Development for Solid Tumor Patients January 27th, 2016
Semblant Appoints Donald Cunningham as Chief Commercial Officer January 2nd, 2016